After receiving input from more than 80 institutions across the United States, the American Society of Health Systems Pharmacists (ASHP) and the American Pharmacists Association (APhA) developed a new medication management care transition guide.
After receiving input from more than 80 institutions across the United States, the American Society of Health Systems Pharmacists (ASHP) and the American Pharmacists Association (APhA) developed a new medication management care transition guide.
“Pharmacists’ leadership is integral to improving patient care throughout the entire medication-use process and all care settings. The programs highlighted in this report demonstrate how to improve medication adherence and reduce adverse drug events and hospital re-admissions,” said Paul W. Abramowitz, PharmD, CEO of ASHP.
The ASHP-APhA Medication Management in Care Transitions Best Practices identifies 8 programs that were distinguished as best practices because of their impacts of the care transitions model on patient care and pharmacist involvement in the transition process from inpatient to home settings. The 8 programs with the best transition programs include: Einstein Healthcare Network, Froedtert Hospital, Hennepin County Medical Center, Johns Hopkins Medicine, Mission Hospitals, Sharp HealthCare, the University of Utah Hospitals and Clinics, and the University of Pittsburgh School of Pharmacy and the University of Pittsburgh Medical Center.
The 8 organizations’ programs best demonstrate that patients benefit from the pharmacists’ medication expertise on care transitions teams. In addition, the successful transitions in these organizations depend on contributions by pharmacists, technicians, student pharmacists, supportive personnel, and other healthcare providers.
CVS Caremark Makes Changes in Diabetes Coverage for 2025
Published: November 25th 2024 | Updated: November 25th 2024CVS Caremark has removed several diabetes drugs favor of newer products and generics, and is even favoring an insulin infusion system developed by a company that was cofounded by Alan Lotvin, a former executive at CVS Health.
Read More
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More